Back to search
Cutaneous Manifestations
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cutaneous Manifestations trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cutaneous Manifestations trials you may qualify forThe purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active cutaneous m…
The purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active cutaneous m…
In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with cutaneous lupus erythematosus (CLE). The study w…
The primary purpose of this study is to evaluate the efficacy, safety, and tolerability of IMVT-1402 in participants with Cutaneous Lupus Erythematosus. The st…
This prospective observational study aims to evaluate and compare the sensory block distribution and regression patterns of two regional anesthesia techniques -…
Multi-center sequential multiple assignment randomized trial comparing the effectiveness of three different standard of care treatment options for patients with…
The purpose of this study is to see if the Zio® monitor device can be worn by children for up to 14-days and to determine if the skin preparation process will p…
In this study, researchers will learn more about a study drug called BIIB059 (litifilimab) in participants with cutaneous lupus erythematosus (CLE). The study w…
The goal of this clinical trial is to determine whether adding a β-glucan moisturizing cream to routine skin care can enhance skin healing, accelerate visible r…